Acute Myeloid Leukemia (AML) at BMCHRC

Common symptoms of AML include Fatigue due to Anemia, shortness of Breath, Pale Skin, easy bruising or bleeding, frequent infections due to Low White Blood Cell counts, Fever, and Swollen Lymph Nodes. However, symptoms can vary depending on the individual and the stage of the disease.

AML is diagnosed through a series of tests including blood tests to evaluate Blood Cell counts and Morphology, Bone Marrow aspiration and Biopsy to examine the Bone Marrow for Leukemia cells, and imaging studies such as X-Rays, CT Scans, or MRIs to assess the extent of the disease.

Treatment for AML typically involves induction chemotherapy to achieve remission, followed by consolidation therapy to prevent relapse. Stem Cell Transplantation may be recommended for certain patients. Other treatment options include Targeted Therapy, which attacks specific Leukemia Cells, and Immunotherapy, which helps the immune system fight cancer cells.

AML patients receive comprehensive supportive care to manage symptoms and side effects of treatment. This may include blood transfusions to manage low blood cell counts, antibiotics to prevent or treat infections, medications to manage pain and nausea, nutritional support, and psychological counseling to address emotional needs.

Yes, recurrence of AML is possible even after achieving remission. Regular follow-up appointments and ongoing monitoring are essential to detect any signs of relapse early and provide timely intervention.

AML patients are encouraged to adopt a healthy lifestyle including regular exercise, balanced nutrition, staying hydrated, and avoiding tobacco and excessive alcohol consumption. It's also essential to follow medical advice regarding activity levels and dietary restrictions during treatment.

The prognosis for AML varies depending on factors such as age, overall health, subtype of AML, genetic mutations, and response to treatment. Early diagnosis and appropriate treatment can significantly impact outcomes, with some patients achieving long-term remission.

Patients can schedule an appointment with our experienced oncology team at BMCHRC for a comprehensive evaluation, diagnosis, and personalized treatment plan. Our multidisciplinary approach ensures that patients receive the best possible care tailored to their individual needs.

AML treatment may cause various side effects including Nausea, Vomiting, Diarrhea, Hair Loss, Fatigue, increased risk of infections due to low White Blood Cell counts, and bleeding or bruising due to low platelet counts. Your healthcare team will monitor and manage these side effects to ensure your comfort and well-being.

Yes, Genetic testing plays a crucial role in AML management. Identifying specific genetic mutations or abnormalities in leukemia cells can help Oncologists determine prognosis, select targeted therapies, and assess eligibility for Clinical Trials. Results from genetic testing provide valuable information that guides treatment decisions and improves outcomes for AML patients.

Stem Cell Transplantation, also known as Hematopoietic Stem Cell Transplantation (HSCT), may be recommended for AML patients who are at high risk of relapse or have achieved remission but have a high likelihood of disease recurrence. The procedure involves replacing diseased bone marrow with healthy stem cells from a compatible donor, allowing for the regeneration of a healthy blood and immune system. HSCT can offer the possibility of long-term remission or cure for some AML patients.

Yes, there is extensive ongoing research and clinical trials focused on advancing treatment options for AML. These studies explore novel therapies, targeted agents, immunotherapies, and combination approaches to improve outcomes and reduce treatment-related toxicity. Participation in clinical trials offers eligible AML patients access to cutting-edge treatments and contributes to the advancement of medical knowledge in the field of leukemia treatment.

AML and its treatment can have long-term effects on patients' health and well-being. These may include increased risk of secondary Cancers, Cardiac complications, Infertility, Cognitive impairment, and Psychological distress. Regular follow-up care and survivorship programs are essential for monitoring and managing these potential long-term effects, promoting overall health, and enhancing quality of life for AML survivors.

Supporting a loved one with AML involves offering emotional support, practical assistance with daily tasks, and accompanying them to medical appointments. Listen attentively to their concerns, provide encouragement, and advocate for their needs within the healthcare system. Educate yourself about AML and its treatment options to facilitate informed discussions and decision-making. Additionally, consider joining support groups or seeking counseling to cope with the emotional challenges associated with a cancer diagnosis.